Academic Journal
Q1Nanomedicine
About Nanomedicine
Nanomedicine is a scholarly journal published by Taylor and Francis Ltd.. SCImago 2025 lists it in Q1, with an SJR of 0.681 and H-index of 148.
Coverage: 2006-2026. Research categories: Development (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Materials Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2).
Source-backed journal facts
Topics in published research
Nanoparticle-Based Drug Delivery; Nanoplatforms for cancer theranostics; RNA Interference and Gene Delivery; Nanoparticles: synthesis and applications; Graphene and Nanomaterials Applications; Advanced biosensing and bioanalysis techniques.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Heat-preconditioned MSC-derived exosomal miR‑486‑5p reverses doxorubicin resistance in breast cancer
Di Xu, Xiaoyan Xu, Fei Deng, Liping Dong et al.
2026-10-01 · DOI: 10.1080/17435889.2026.2739511Sensitizing nanomedicine for platinum-resistant ovarian cancer
Diana Hsin-Yu Lee, William Lee, Horacio Bach
2026-09-28 · DOI: 10.1080/17435889.2026.2738705Opportunities and challenges of nanomedicine for muscular dystrophy
UB Bishnupriya, Debadatta Mohapatra
2026-09-27 · DOI: 10.1080/17435889.2026.2735437Macrophage-derived exosomes carrying RAD50 attenuate oxidative DNA damage and p53–p21-dependent S-phase arrest in spermatogenic cells
Jiahua Meng, Zitong Zhang, Ning Li, Qiang Li et al.
2026-09-20 · DOI: 10.1080/17435889.2026.2735438Applications of Prussian blue nanoparticles in the treatment of neurodegenerative diseases
M. Antonia Busquets, Raimon Sabaté, Irene Álvarez-Berbel, Alba Espargaró et al.
2026-09-17 · DOI: 10.1080/17435889.2026.2734070Neuroinflammation and peripheral targeting: formulation-based strategies for modulating the neuroimmune axis in diabetic peripheral neuropathy
Monami Bhattacharyya, Papiya Mitra Mazumder
2026-09-17 · DOI: 10.1080/17435889.2026.2734072Preclinical advances on diosgenin-loaded nanomedicines
Mariana Matias, Ana Sofia Martins, Samuel Silvestre
2026-09-17 · DOI: 10.1080/17435889.2026.2734068Multifunctional nanoplatforms nanomedicine–device combination products: a translational maturity framework spanning nanocoated implants, theranostic platforms, wearable nanosensors, drug-eluting devices, intratumoral nanoparticle injections, and inorganic hybrid nanoplatforms
Abhisar Sahu, Saman Fatima
2026-09-17 · DOI: 10.1080/17435889.2026.2732004The Italian Nanomedicine Platform (INP): national integration within the European nanomedicine ecosystem
Giovanni Tosi, Marco Rossi, Laura Calzà, Marta Valenza et al.
2026-09-17 · DOI: 10.1080/17435889.2026.2732003CRISPR-Cas9‑based lipid nanocarriers for advanced therapy of urinary bladder cancer
Swarupananda Mukherjee, Dipanjan Karati, Sinjini Sarkar, Dipanjana Ash et al.
2026-09-17 · DOI: 10.1080/17435889.2026.2732014Fluorescently labeled Angiopep-2-conjugated-PAMAM nanoparticles to evaluate drug brain-targeted delivery performance
Xingyue Li, Jianxiang Wang, Yifei Wang, Fangfang Hu et al.
2026-09-02 · DOI: 10.1080/17435889.2026.2724581Dendrimer ‘protein corona’: mechanism of interaction, characterization, and implications in drug delivery
Hongyu Feng, Evelyn Chang, Elijah J. Walthall, Andy Yang et al.
2026-09-02 · DOI: 10.1080/17435889.2026.2729126Mucus-penetrating nanocarriers for the enhanced oral delivery of antibody drugs
Mireia Del Valle, Ainhoa Huidobro, Miriam Arellano, Juan M. Irache et al.
2026-09-02 · DOI: 10.1080/17435889.2026.2729135A novel rosiglitazone-phosphatidylserine composite nanoparticle mediated targeted drug delivery to macrophages for treatment of ulcerative colitis
Ruihan Zou, Min Wang, Xiaohan Jiang, Hao Wu et al.
2026-09-02 · DOI: 10.1080/17435889.2026.2729127Recent advances in the application of electrospun nanofibrous scaffolds in bone regeneration
Mariana Chaves Santos, André Diniz Rosa Silva, Millena de Cássia de Sousa e Silva, Manuel Henrique de Sousa Cunha et al.
2026-09-02 · DOI: 10.1080/17435889.2026.2729140Insights into the use of artificial intelligence in the drug discovery and delivery of nanosystems for the treatment of infectious diseases and neoplasms
Vinicius Martinho Borges Cardoso, Camila Rodrigues Santana, Giovanna Justino Momente, Annelize Rodrigues Gomes et al.
2026-09-02 · DOI: 10.1080/17435889.2026.2725124Ultrasound-responsive microencapsulated curcumin nanobubbles for treatment of mice rheumatoid arthritis and mechanistic insights based on single-cell Transcriptomics
Yuewen Qiu, Haixia Xu, Shali Jiang, Wensi Zuo et al.
2026-08-18 · DOI: 10.1080/17435889.2026.2721648Astragaloside IV and rapamycin co-loaded bone marrow mesenchymal stem cell-derived exosome nanocarriers for targeted modulation of the PI3K/Akt/mTOR pathway in hepatocellular carcinoma
Jing Zhang, Dongdong Gao
2026-08-18 · DOI: 10.1080/17435889.2026.2698784Understanding Mycobacterium tuberculosis host immune responses and identifying synergistic autophagy-inducing compounds as potential nanomedicines for tuberculosis treatment
Athembile Centane, Retsepile Ephraim Maphasa, Admire Dube
2026-08-18 · DOI: 10.1080/17435889.2026.2721658Nanoparticles for fluorescence-guided breast cancer surgery: advances in in vivo preclinical research
Niloofar Zahraie, Alexandru Chivu, Alexander J. MacRobert, Hirak Patra et al.
2026-08-18 · DOI: 10.1080/17435889.2026.2715009Reviews
Community Reviews
Version History
October 2, 2026 at 9:07 pm
October 2, 2026